The 50-page lawsuit claims the actions of the labs has violated state law, intentionally interfered with MCR’s business ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Framingham facility alleges that labs who manipulate cannabis safety testing are enriching themselves at their expense.
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham.
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
A Massachusetts doctor ... and June 2023 during medical examinations at Charles River Medical Associates in Framingham.Todd resigned from Brigham and Women's in 2023, as the hospital was moving ...
FDA Proposes Nutrition Labels On Front Of Food Packages To Fight Chronic Disease The Food and Drug Administration has proposed moving nutrition labels to the front of most packaged foods, aiming to ...
The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...